This is a non-core endpoint: only basic statistics are computed.
Lethal midline granuloma
DOID EFO MESH Endpoint Browser
M13_MIDGRANULOMA
lethal midline granuloma: An aggressive, progressive, and destructive lesion affecting the nasal cavities, paranasal sinuses, and the palate. The vast majority of cases are malignant lymphoproliferations affecting the midline of the face in patients with nasal type extranodal NK/T-cell lymphoma.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
19
Check minimum number of events None
19
Include endpoints None
19
Remove individuals based on genotype QC
19
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Lethal midline granuloma based on the number of shared cases.
Broader endpoints:
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Diseases of the musculoskeletal system and connective tissue
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 19 | 11 | 8 |
Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
Mean age at first event (years) | 51.41 | 50.38 | 52.82 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: M13_MIDGRANULOMA – Lethal midline granuloma
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Lethal midline granuloma
↥Endpoint not on priority list, no data to show.